# Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

> **NCT07089784** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 64 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** MK-2828
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07089784
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2026-05-06
- **Final completion:** 2026-05-06
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089784, "Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07089784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*